Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: Talimogene laherparepvec|DRUG: Atezolizumab
Sponsor: SOLTI Breast Cancer Research Group
Collaborators: Amgen|Roche Pharma AG